In a new article via marketresearch.com, “China possesses a large healthcare market that is indispensable for overseas and multinational pharmaceutical companies. In 2014, the total value of drugs in the Chinese healthcare market reached RMB 1332.6 billion (approx. US$214.9 billion). Imported drugs made by overseas and multinational companies accounted for around one-fourth of the Chinese healthcare market.”  For more information on these developments, please visit: http://blog.marketresearch.com/the-multinational-pharmaceutical-giants-query-changing-chinese-market-regulations